Atlas Trials

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Clinical trial NCT06063486 · RECRUITING

Trial details

NCT number
NCT06063486
Sponsor
University of Southern California
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Clonal Cytopenia of Undetermined SignificanceEssential ThrombocythemiaMyelodysplastic SyndromeMyelofibrosisPolycythemia Vera
Start date
2024-03-01
Primary completion
2026-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.